Less frequently, normocytic anemia is a complication from a particular medication. Symptoms of normocytic anemia are slow to develop and are similar to other subtypes. Many people don’t ...

Darbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced ...

A review of targeted therapies for anemia in patients with lower-risk myelodysplastic syndromes and myelofibrosis that improve transfusion independence and hemoglobin levels.

Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or ...

Aplastic anemia usually results in the immune system damaging bone marrow stem cells. Other potential causes include: medications exposure to toxins inherited genetic changes Aplastic anemia can ...

Erythropoiesis-stimulating agent (ESA) treatment before or early after regular transfusion therapy improved overall survival ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New York Post.

Sickle cell anemia, first described in 1910, primarily affects people of African, Mediterranean and Middle Eastern descent.

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life, with doctors declaring him ...